Immediate Impact

1 by Nobel laureates 3 from Science/Nature 74 standout
Sub-graph 1 of 17

Citing Papers

Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2025 Standout
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
42 intermediate papers

Works of Roopinder Gillmore being referenced

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
2013
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization
2011

Author Peers

Author Last Decade Papers Cites
Roopinder Gillmore 670 317 228 361 323 48 1.3k
María Teresa García de Dávila 342 439 273 225 378 63 1.5k
Andrea Gardini 429 527 279 655 376 40 1.3k
S. Bretti 389 249 232 551 136 33 1.2k
J.Y. Scoazec 444 207 142 206 342 35 1.2k
Stacey Stein 780 253 377 342 274 74 1.4k
Pilar Lardelli 637 102 441 274 332 71 1.5k
Michiyoshi Hisanaga 634 691 213 472 261 54 1.7k
Henrik Roed 738 300 508 226 230 53 1.7k
Mashaal Dhir 672 610 336 379 262 53 1.5k
Isabella Morra 291 439 176 185 193 42 1.2k

All Works

Loading papers...

Rankless by CCL
2026